Trump Administration Moves to Cut Agency Facility Leases

President Trump is making moves to reduce expenses by canceling leases for various federal agencies’ facilities. Among these is the EPA’s human research facility located at the University of North Carolina at Chapel Hill. “Scientists are making efforts to save it,” according to a report from Nature magazine. Arguably, the most intriguing aspect of this notorious lab is the question of whether it’s an inefficient use of funds.

Through the Freedom of Information Act, I uncovered some alarming details about the lab’s experiments involving air pollutants deemed dangerous by the EPA. Central to these experiments are actual gas chambers where exhaust from a diesel truck running in the parking lot is funneled in. Images of this disturbing setup are available online.

After eliminating carbon monoxide, the EPA concentrated on particulate matter in the exhaust, known as PM2.5. This particulate matter was administered at extremely high levels to human participants, who inhaled it in the chamber for two hours. It raises serious concerns about the purpose of these studies, especially since many of the subjects were individuals with pre-existing conditions like asthma, heart disease, or diabetes. The EPA compensated participants for their involvement, which undoubtedly adds a layer of complexity to the ethical considerations.

While it might seem benign at first glance, one has to wonder about the implications. PM2.5 is considered one of the most toxic substances known to humans, capable of causing death within hours of inhalation. The groups most vulnerable to such exposure were precisely the ones being tested—those with heart disease, diabetes, and older adults. It’s troubling that the EPA failed to communicate this risk, thus neglecting to secure the legally required “informed consent” from participants. Instead of giving clear written notices indicating the potential dangers of these experiments, the agency’s disclosures only hinted that minor respiratory issues could occur.

Upon discovering these troubling practices, our group opted to take action and sued the federal agency to halt the experiments. The documents that surfaced during the lawsuit revealed some shocking truths, including instances of hospitalizations among participants.

One EPA employee’s affidavit detailed a verbal warning given to participants, informing them that they “could die from this experiment.” It’s perplexing how this kind of essential information could be communicated verbally alone, as history has shown us the perils of conducting non-therapeutic medical experiments without proper consent.

The Department of Justice must have been taken aback by a memo the EPA submitted, which ultimately admitted that the scientific basis for categorizing PM2.5 as lethal was hardly adequate. The implication was concerning—did the EPA conduct these experiments to generate data to substantiate a hypothesis about PM2.5’s deadly effects? That feels like a serious ethical violation.

Fortunately, the EPA later claimed that no one was harmed in the experiments, stating that participants did not experience significant adverse effects.

Despite the revelations, the court ultimately dismissed the lawsuit based on a technicality, ruling that only the actual human subjects could file a suit due to the EPA’s initial deceit. Although the agency faced public scrutiny, they attempted to reposition themselves through an investigation, but those efforts didn’t seem to be fruitful.

Fast forward to today, and the consequences of the EPA’s unethical experiments are pressing. The Trump administration now has to address these concerns while executing its deregulation plans.

During the Clinton, Obama, and Biden administrations, PM2.5 regulations formed the basis of numerous air quality rules. In line with this, the Trump EPA recently announced plans to roll back these regulations.

Initially established under Obama and Biden, these regulations struggled to meet standard cost-benefit analyses. To justify these rules politically, claims were made that new regulations would effectively reduce PM2.5 emissions by controlling greenhouse gases and mercury from coal plants. Given the EPA’s previous claim that PM2.5 contributed to the deaths of about 570,000 Americans annually, the challenge was reconciling the claimed benefits of the rules with the likelihood of their substantial costs.

However, it has become clear that many of the EPA’s assertions regarding PM2.5 were unfounded, revealed through these illegal human experiments. Closing down the infamous lab is just the first step, but the agency must now also reconsider the regulatory justifications based on these flawed human studies.